These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8731307)

  • 21. Development and evaluation committees' methods for appraising new drugs. Committee failed to meet aims in producing report on low molecular weight heparins.
    Bosanquet N; Fox K
    BMJ; 2000 Mar; 320(7236):714-5. PubMed ID: 10710594
    [No Abstract]   [Full Text] [Related]  

  • 22. Heparin in acute coronary disease--requiem for a heavyweight?
    Armstrong PW
    N Engl J Med; 1997 Aug; 337(7):492-4. PubMed ID: 9250854
    [No Abstract]   [Full Text] [Related]  

  • 23. Low molecular weight heparins better than unfractionated heparin in unstable coronary artery disease? Unstable angina pectoris/non-Q wave infarction a partly outpatient clinic condition?
    Kauw FH; Cleophas TJ; Kalmansohn RB
    Int J Clin Pharmacol Ther; 1998 Jul; 36(7):392-7. PubMed ID: 9707355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-molecular weight heparins.
    Talley JD
    J Ark Med Soc; 1997 Apr; 93(11):555-6. PubMed ID: 9114648
    [No Abstract]   [Full Text] [Related]  

  • 25. Low molecular weight heparins in the treatment of unstable angina.
    Ageno W; Turpie AG
    Minerva Cardioangiol; 2002 Dec; 50(6):643-51. PubMed ID: 12473984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The value of low-molecular-weight heparins in the treatment of acute coronary syndrome].
    Carlsson J; Tebbe U
    Dtsch Med Wochenschr; 2002 Apr; 127(16):859-65. PubMed ID: 11961704
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antiplatelets and anticoagulants in acute coronary syndromes: levels of evidence].
    Páramo JA; García R; Rodríguez P; de Gaona ER
    Rev Med Univ Navarra; 2007; 51(1):23-7. PubMed ID: 17555117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Medical treatment of acute coronary syndrome without ST-segment elevation].
    Collet JP; Choussat R; Montalescot G
    Rev Prat; 2003 Mar; 53(6):624-8. PubMed ID: 12749148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Heparin therapy and coronary cardiopathy].
    Branzi A; Melandri G
    Cardiologia; 1996 Dec; 41(12):1147-54. PubMed ID: 9064212
    [No Abstract]   [Full Text] [Related]  

  • 30. Approaches to the treatment of unstable angina and non-Q wave myocardial infarction.
    Cohen M
    Can J Cardiol; 1998 Aug; 14 Suppl E():11E-14E. PubMed ID: 9779027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low molecular weight heparin in acute coronary syndromes.
    Cannon CP
    Curr Cardiol Rep; 1999 Sep; 1(3):206-11. PubMed ID: 10980843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unstable angina and non-Q-wave myocardial infarction. Treatment beyond aspirin and heparin.
    Theroux P
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):799. PubMed ID: 12497824
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of un-fractionated heparin and low molecular weight heparin on hospital mortality in patients with non ST elevation acute coronary syndrome (ACS).
    Angkasuwapala K; Ratanasumawong K; Ngarmukos T; Kehasukcharoen W; Boonsom W; Kamsa-ard S
    J Med Assoc Thai; 2007 Oct; 90 Suppl 1():109-14. PubMed ID: 18431893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological and clinical evidence for the use of low-molecular-weight heparins in acute coronary syndromes.
    Rosito GA; Silva OB; Ribeiro JP
    Arq Bras Cardiol; 2001 Aug; 77(2):184-95. PubMed ID: 11514830
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac events in women with unstable angina/non-ST-elevation myocardial infarction (PRISM-PLUS Study).
    Huynh T; Theroux P; Snapinn S; Wan Y;
    Am Heart J; 2003 Oct; 146(4):668-73. PubMed ID: 14564321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of low molecular weight heparin on unstable angina].
    Jiang DQ; Wen D; Zhou SH
    Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):340-2. PubMed ID: 12536729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute coronary syndromes: new developments in pharmacological treatment strategies.
    Gylys K; Gold M
    Crit Care Nurse; 2000 Apr; Suppl():3-14; quiz 15-6. PubMed ID: 11876169
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of unstable angina and myocardial infarction.
    Cohen M; Turpie AG
    Lancet; 2000 Sep; 356(9236):1193-4. PubMed ID: 11030322
    [No Abstract]   [Full Text] [Related]  

  • 39. Heparin should be administered to every patient admitted to the hospital with possible unstable angina.
    Brewster GS; Herbert ME
    West J Med; 2000 Aug; 173(2):138-40. PubMed ID: 10924445
    [No Abstract]   [Full Text] [Related]  

  • 40. [Coronary insufficiency and heparin].
    Nicolau JC; Ramires JA
    Arq Bras Cardiol; 1991 Aug; 57(2):141-50. PubMed ID: 1823773
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.